Abstract

CRISPR/Cas9 is a powerful tool for genome editing in cells and organisms. Nevertheless, introducing directed templated changes by homology-directed repair (HDR) requires the cellular DNA repair machinery, such as the MRN complex (Mre11/Rad50/Nbs1). To improve the process, we tailored chimeric constructs of Cas9, in which SpCas9 was fused at its N- or C-terminus to a 126aa intrinsically disordered domain from HSV-1 alkaline nuclease (UL12) that recruits the MRN complex. The chimeric Cas9 constructs were two times more efficient in homology-directed editing of endogenous loci in tissue culture cells. This effect was dependent upon the MRN-recruiting activity of the domain and required lower amounts of the chimeric Cas9 in comparison with unmodified Cas9. The new constructs improved the yield of edited cells when making endogenous point mutations or inserting small tags encoded by oligonucleotide donor DNA (ssODN), and also with larger insertions encoded by plasmid DNA donor templates. Improved editing was achieved with both transfected plasmid-encoded Cas9 constructs as well as recombinant Cas9 protein transfected as ribonucleoprotein complexes. Our strategy was highly efficient in restoring a genetic defect in a cell line, exemplifying the possible implementation of our strategy in gene therapy. These constructs provide a simple approach to improve directed editing.

Highlights

  • CRISPR and Cas (CRISPR-associated) proteins are part of the RNA-based adaptive immune system in bacteria and archaea [1]

  • RNA is used in which the CRISPR RNA with homology to the target site is fused in a chimeric construct to the trans-activating crRNA [7]

  • Homology-directed genome editing using the CRISPR/Cas9 system is hampered by the reliance on the cellular DNA repair machinery, which usually favors non-homologous end joining (NHEJ) over homologous recombination (HR)

Read more

Summary

Introduction

CRISPR (clustered regularly interspaced short palindromic repeat) and Cas (CRISPR-associated) proteins are part of the RNA-based adaptive immune system in bacteria and archaea [1]. This system has been adapted to create simplified tools for site-specific cleavage of genomic DNA in a wide variety of organisms [2,3,4,5,6]. Cas is a DNA endonuclease, which is targeted to a specific target site by an RNA guide sequence complementary to the target sequence. The CRISPR/Cas9-mediated double-strand break (DSB) is usually repaired by the endogenous cell repair machinery, either by non-homologous end joining (NHEJ) or homologous recombination (HR), with NHEJ acting as the predominant repair pathway. NHEJ is highly efficient but error prone, and produces small insertions or deletions (indels), generally resulting in frame-shift mutations, which can effectively inactivate a Biomolecules 2019, 9, 584; doi:10.3390/biom9100584 www.mdpi.com/journal/biomolecules

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call